Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy

Author： Bachmann W.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.10, 2003-01, pp. : 679-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus

By Segal Pesach  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 589-595

Adis International

Access to resources Recommend Favorite

Pioglitazone provides greater long-term glycaemic control than glibenclamide [glyburide] in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen  

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Preferred insulin analogue regimens in poorly controlled type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea

By Aronson Ronnie  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1535-1539

Informa Healthcare

Access to resources Recommend Favorite